Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meirav Pevsner-Fischer

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Stem Cells (Dayton, Ohio)|April 10, 2014
Cell isolation induces fate changes of bone marrow mesenchymal cells leading to loss or alternatively to acquisition of new differentiation potentialsOfer Shoshani, Orly Ravid, Hassan Massalha, et al.
World Journal of Clinical Oncology|April 16, 2016
Role of the microbiome in non-gastrointestinal cancersMeirav Pevsner-Fischer, Timur Tuganbaev, Mariska Meijer, et al.
Immunology and Cell Biology|January 23, 2018
The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiotaZoya Alteber, Adi Sharbi-Yunger, Meirav Pevsner-Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signalingAlexandra Zanin-Zhorov, Guy Tal-Lapidot, Liora Cahalon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Heat shock protein 60 activates B cells via the TLR4-MyD88 pathwayMichal Cohen-Sfady, Gabriel Nussbaum, Meirav Pevsner-Fischer, et al.
Blood|October 14, 2006
Toll-like receptors and their ligands control mesenchymal stem cell functionsMeirav Pevsner-Fischer, Vered Morad, Michal Cohen-Sfady, et al.
Stem Cell Reviews and Reports|September 2, 2011
Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factorMeirav Pevsner-Fischer, Sarit Levin, Tal Hammer-Topaz, et al.
Plos One|November 13, 2008
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent mannerAlina Molchadsky, Igor Shats, Naomi Goldfinger, et al.
Circulation|December 10, 2009
Patient characteristics and cell source determine the number of isolated human cardiac progenitor cellsAyelet Itzhaki-Alfia, Jonathan Leor, Ehud Raanani, et al.
Experimental Cell Research|March 31, 2009
Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6Nili Dezorella, Meirav Pevsner-Fischer, Varda Deutsch, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Stem Cells (Dayton, Ohio)|April 10, 2014
Cell isolation induces fate changes of bone marrow mesenchymal cells leading to loss or alternatively to acquisition of new differentiation potentialsOfer Shoshani, Orly Ravid, Hassan Massalha, et al.
World Journal of Clinical Oncology|April 16, 2016
Role of the microbiome in non-gastrointestinal cancersMeirav Pevsner-Fischer, Timur Tuganbaev, Mariska Meijer, et al.
Immunology and Cell Biology|January 23, 2018
The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiotaZoya Alteber, Adi Sharbi-Yunger, Meirav Pevsner-Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signalingAlexandra Zanin-Zhorov, Guy Tal-Lapidot, Liora Cahalon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Heat shock protein 60 activates B cells via the TLR4-MyD88 pathwayMichal Cohen-Sfady, Gabriel Nussbaum, Meirav Pevsner-Fischer, et al.
Blood|October 14, 2006
Toll-like receptors and their ligands control mesenchymal stem cell functionsMeirav Pevsner-Fischer, Vered Morad, Michal Cohen-Sfady, et al.
Stem Cell Reviews and Reports|September 2, 2011
Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factorMeirav Pevsner-Fischer, Sarit Levin, Tal Hammer-Topaz, et al.
Plos One|November 13, 2008
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent mannerAlina Molchadsky, Igor Shats, Naomi Goldfinger, et al.
Circulation|December 10, 2009
Patient characteristics and cell source determine the number of isolated human cardiac progenitor cellsAyelet Itzhaki-Alfia, Jonathan Leor, Ehud Raanani, et al.
Experimental Cell Research|March 31, 2009
Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6Nili Dezorella, Meirav Pevsner-Fischer, Varda Deutsch, et al.
Pageof 5